fbpx Skip to main content
 

Search

Janssen Search

Search results

762 SEARCH RESULTS FOR

research-development

Not finding what you're looking for? Visit Janssen in your country.
PAGE 71 OF 77

Pages

Advancing the Power and Promise of Monoclonal Antibodies Janssen was one of the first companies to recognize the diagnostic and therapeutic potential of monoclonal antibodies, and today we are continuing to apply that expertise to explore their power and ...

Cardiovascular, Metabolism & Retina At Janssen Cardiovascular, Metabolism (CVM) & Retina, we take on the most pervasive diseases that burden hundreds of millions of people and healthcare systems around the world. As part of this long-standing ...

Collaboration with the International Partnership for Microbicides Women and girls, particularly in sub-Saharan Africa where the HIV epidemic has hit hardest, remain particularly vulnerable to infection. New HIV prevention tools are needed to empower women ...

Article Type:  Infectious Diseases & Vaccines For Patients & Caregivers We are focused on tackling complex infectious diseases, finding the right paths of intervention, and ensuring they reach those in need. We are committed to empowering patients ...

  Commercialization Focusing our efforts in raising the bar for pulmonary hypertension (PH) management. At Janssen, we are focusing our worldwide scientific and commercial expertise to help raise the bar in the management of PH. Janssen brings to the PH ...

RICHARD APPIAH VICE PRESIDENT DISEASE AREA COMMERCIAL LEADER GASTROENTEROLOGY Richard Appiah is Vice President, Disease Area Commercial Leader, Gastroenterology for the Immunology Therapeutic Area at Janssen Global Services. In this role, he is ...

Article Block Text:  Article Type:  Compassionate Use & Pre-Approval Access Questions to ask your doctor If you and your doctor are considering the use of investigational medicines that have not yet been approved by government health authorities, ...

Article Type:  Explore Patient Involvement- The Sooner, The Better, says Janssen's Wooding by Belen Diego at Eyeforpharma Barcelona BARCELONA, March 17, 2017 (APM)- Janssen's head of global commercial strategy organisation supports moves to ...

Colorectal Cancer Colorectal cancer (CRC) is the third most common cancer worldwide, with over 1.8 million new cases in 2018 alone. 1 The most common hereditary CRC syndromes are familial adenomatous polyposis (FAP) and lynch syndrome (LS). Frequent ...

Using Cancer as Motivation, Art as Therapy Aug 05, 2019 Cancer survivor and artist Sebastián Rodríguez. “My illness motivated me.” Sebastián Rodríguez (also known as Drouville) is a graphic designer and a painter in Buenos Aires, Argentina. His multiple ...

762 SEARCH RESULTS FOR

research-development

Not finding what you're looking for? Visit Janssen in your country.
PAGE 71 OF 77

Pages